J. Reiffers

F. Moreau-Gaudry, J. Reiffers, J. D. Di Santo, 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Hematopoietic reconstitution after autologous blood stem cell transplantation: A report of 46 cases

G. Leverger, H. Tilly, É. Lepage, 1987 .

No impact of high‐dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission

J. Sierra, M. Labopin, D. Blaise, 2000, British journal of haematology.

Early allogeneic transplantation favorably influences the outcome of adult patients suffering from acute myeloid leukemia

H. Tilly, D. Blaise, J. Reiffers, 1997, Bone Marrow Transplantation.

A prospective randomized trial of idarubicin vs daunorubicin in combination chemotherapy for acute myelogenous leukemia of the age group 55 to 75.

J. Reiffers, P. Berthaud, P. Hurteloup, 1996, Leukemia.

Allogeneic bone marrow transplantation remains an efficient consolidation for adults with acute myeloid leukemia even when performed very soon after diagnosis (< 100 days). The SFGM (Société Française de Greffe de Moelle.

J. Reiffers, E. Archimbaud, N. Ifrah, 1995, Leukemia.

Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osseuse [see comments]

D. Blaise, J. Reiffers, E. Archimbaud, 1992 .

Role of high-dose therapy with peripheral blood progenitor cell support in multiple myeloma.

J. Reiffers, G. Marit, J. Boiron, 1995, Journal of hematotherapy.

Autologous stem cell transplantation versus chemotherapy for adult patients with acute myeloid leukemia in first remission: the BGMT Group experience.

P. Cony-Makhoul, D. Blaise, J. Reiffers, 1993, Nouvelle revue francaise d'hematologie.

Response at Three Months Is a Good Predictive Factor for Newly Diagnosed Chronic Myeloid Leukemia Patients Treated by Recombinant Interferon-Presented in part at the 38th annual meeting of the American Society of Hematology, Orlando, FL, December 6-10, 1996.

P. Cony-Makhoul, J. Reiffers, G. Marit, 1998 .

Response at three months is a good predictive factor for newly diagnosed chronic myeloid leukemia patients treated by recombinant interferon-alpha.

P. Cony-Makhoul, J. Reiffers, G. Marit, 1998, Blood.

Purged Autologous Bone Marrow: Better or Worse than Circulating Stem Cells?

J. Reiffers, 1991 .

Autologous blood cell vs marrow transplantation for acute myeloid leukemia in complete remission: an EBMT retrospective analysis

M. Labopin, D. Blaise, J. Reiffers, 2000, Bone Marrow Transplantation.

Study of the apoptosis induced in vitro by antitumoral drugs on leukaemic cells.

J. Vial, F. Lacombe, J. Reiffers, 1997, Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis.

Expression of interferon- a (IFN- a ) receptor 2c at diagnosis is associated with cytogenetic response in IFN- a –treated chronic myeloid leukemia

J. Reiffers, G. Marit, F. Mahon, 2001 .

Autologous blood stem cell transplantation versus autologous bone marrow transplantation for acute myeloid leukemia in first complete remission. The EBMT Group Working Party for Autologous Bone Marrow Transplantation.

M. Labopin, J. Reiffers, N. Gorin, 1991, Bone marrow transplantation.

Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Societe Francaise de Greffe de Moelle

Marie-Cécile Michallet, Bruno Lioure, C. Chastang, 1996 .

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.

Francisco Cervantes, Klaus Lechner, Thomas Fischer, 2003, The New England journal of medicine.

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia.

Francisco Cervantes, Thomas Fischer, Alois Gratwohl, 2006, The New England journal of medicine.

Nilotinib Demonstrates Superior Efficacy Compared with Imatinib in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase: Results From the International Randomized Phase III ENESTnd Trial

R. Larson, R. Clark, H. Kantarjian, 2009 .

Dasatinib 140 Mg Once Daily (QD) Has Equivalent Efficacy and Improved Safety Compared with 70 Mg Twice Daily (BID) in Patients with Imatinib-Resistant or -Intolerant Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL): 2-Year Data from CA180- 035

R. Larson, G. Martinelli, J. Reiffers, 2008 .

Factors influencing haemopoietic recovery following chemotherapy-mobilised autologous peripheral blood progenitor cell transplantation for haematological malignancies: a retrospective analysis of a 10-year single institution experience

P. Cony-Makhoul, F. Lacombe, J. Reiffers, 1998, Bone Marrow Transplantation.

Multicenter randomized study comparing cyclosporine-A alone and antithymocyte globulin with prednisone for treatment of severe aplastic anemia.

A. Baruchel, G. Leverger, J. Reiffers, 1992, Blood.

Stem cell factor in combination with filgrastim after chemotherapy improves peripheral blood progenitor cell yield and reduces apheresis requirements in multiple myeloma patients: a randomized, controlled trial.

A. Grañena, J. Reiffers, R. Schots, 1999, Blood.

Quantitation of resistance of leukemic cells to cytosine arabinoside from BrdUrd/DNA bivariate histograms.

F. Lacombe, J. Reiffers, F. Belloc, 1992, Cytometry.

Cytokine-mediated expansion of 5-FU-resistant peripheral blood stem cells.

F. Lacombe, J. Reiffers, P. Dumain, 1995, Experimental Hematology.

Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983–93 and 1994–98 at European Group for Blood and Marrow Transplantation centres

G. Gahrton, N. Russell, R. Willemze, 2001, British journal of haematology.

Expansion and differentiation of haemopoietic progenitor cells on endothelialized hydroxyapatite under static conditions

L. Bordenave, F. Lacombe, C. Baquey, 1999, British journal of haematology.

ANTI-LFA1 MONOCLONAL ANTIBODY AND BONE MARROW GRAFT REJECTION IN ADULTS

J. Reiffers, D. Maraninchi, M. Delaage, 1988, The Lancet.

Selective depletion of marrow‐T cytotoxic lymphocytes (CD8) in the prevention of graft‐versus‐host disease after allogeneic bone‐marrow transplantation

J. Reiffers, D. Maraninchi, C. Mawas, 1988, Transplant international : official journal of the European Society for Organ Transplantation.

Autologous blood stem cell transplantation for chronic granulocytic leukaemia in transformation: a report of 47 cases

P. Cony-Makhoul, F. Lacombe, J. Reiffers, 1991, British journal of haematology.

A controlled trial of recombinant human erythropoietin after bone marrow transplantation.

F. Mandelli, S. Burdach, J. Reiffers, 1994, Blood.

The rat Mist1 gene: structure and promoter characterization.

J. Reiffers, J. Ripoche, A. Brown, 2000, Gene.

Stem cell apheresis in patients with acute nonlymphocytic leukemia

J. Reiffers, G. Marit, J. Chevaleyre, 1988 .

Pro-survival role of p62 during granulocytic differentiation of acute myeloid leukemia cells

M. Tschan, E. Ségal-Bendirdjian, J. Reiffers, 2014, Molecular & cellular oncology.

Vascular endothelial lesion in patients undergoing bone marrow transplantation.

A. Blann, J. Reiffers, J. Amiral, 1996, Bone marrow transplantation.

Oral Idarubicin and Low Dose Cytarabine as the Initial Treatment of Acute Myeloid Elderly Patients in Leukemia

J. Reiffers, P. Hurteloup, P. Collombat, 1991 .

Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT).

M. Labopin, G. Meloni, J. Reiffers, 1996, Bone marrow transplantation.

Syngeneic transplantation in multiple myeloma – a case-matched comparison with autologous and allogeneic transplantation

G. Gahrton, A. Gratwohl, J. Reiffers, 1999, Bone Marrow Transplantation.

Chronic myeloid leukemia in first chronic phase not responding to α-interferon: outcome and prognostic factors after autologous transplantation

G. Meloni, J. Reiffers, C. Carlo-Stella, 1999, Bone Marrow Transplantation.

Anti-LFA1 monoclonal antibody (25.3) for treatment of steroid-resistant grade III–IV acute graft-versus-host disease

D. Olive, D. Blaise, J. Reiffers, 1991 .

Autografting for chronic granulocytic leukemia in transformation.

J. Reiffers, P. Hervé, D. Maraninchi, 1986, Journal of the National Cancer Institute.

Blood cell transplantation: past, present and future.

J. Reiffers, R. Lowenthal, J. Boiron, 1996, Hematology and cell therapy.

Anti‐LFA1 monoclonal antibody (25.3) for treatment of steroid‐resistant grade III‐IV acute graft‐versus‐host disease

D. Olive, D. Blaise, J. Reiffers, 1991, Transplant international : official journal of the European Society for Organ Transplantation.

Autologous bone marrow transplantation for first remission acute myeloblastic leukemia in patients older than 50 years: a retrospective analysis of the European Bone Marrow Transplant Group.

F. Mandelli, M. Labopin, A. Gratwohl, 1995, Blood.

Use of Recombinant Interleukin-2 (RU 49637) After Autologous Bone Marrow Transplantation in Patients with Hematological Disease: Phase I–II Study

D. Olive, D. Blaise, J. Reiffers, 1992 .

Effect of stem cell factor on leukemic progenitor cell growth and sensitivity to cytosine-arabinoside.

F. Lacombe, J. Reiffers, J. Viallard, 1996, Leukemia research.

Comparative cost of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission.

J. Reiffers, G. Marit, M. Saux, 1992, Bone marrow transplantation.

Treatment of hematological malignancies relapsing after allogeneic bone marrow transplantation.

P. Cony-Makhoul, J. Reiffers, A. Pigneux, 1994, Blood reviews.

Acute Graft-Versus-Host Disease: Grade and Outcome in Patients With Chronic Myelogenous Leukemia

P. Bartolomeo, G. Gahrton, J. Hermans, 2000 .

Retroviral Coexpression of IFN-α and IFN-γ Genes and Inhibitory Effects in Chronic Myeloid Leukemia Cells

C. Ged, J. Reiffers, H. Verneuil, 2000 .

Improving the cytogenetic response to interferon alpha by zidovudine (AZT) in an HIV-positive chronic myelogenous leukemia patient.

P. Cony-Makhoul, J. Reiffers, J. Pellegrin, 1997, Leukemia & lymphoma.

Peripheral blood stem cell transplantation followed by recombinant alpha interferon for chronic myelogenous leukemia in chronic phase: Preliminary results

J. Reiffers, V. Leblond, D. Caillot, 1993, Stem cells.

Bone marrow transplantation in multiple myeloma: report from the European Cooperative Group for Bone Marrow Transplantation.

G. Gahrton, A. Gratwohl, J. Reiffers, 1987, Blood.

Autologous peripheral blood stem cell transplantation (PBSCT) in acute myeloid leukaemia (AML) in first complete remission (CR) a report of the BGMT cooperative group about 32 patients

P. Cony-Makhoul, D. Blaise, J. Reiffers, 2000 .

Does more intensive treatment cure more patients with acute myeloid leukemia? The BGMT Group.

J. Reiffers, G. Marit, D. Maraninchi, 1991, Seminars in hematology.

Idarubicin in the treatment of relapsed or refractory acute myeloid leukemia.

J. Reiffers, P. Hurteloup, P. Dufour, 1987, Cancer treatment reports.

Early allogeneic stem-cell transplantation for young adults with acute myeloblastic leukemia in first complete remission: an intent-to-treat long-term analysis of the BGMT experience.

J. Rossi, B. Esterni, D. Blaise, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Influence of the fractionation of total body irradiation on complications and relapse rate for chronic myelogenous leukemia. The Groupe d'Etude des greffes de moelle osseuse (GEGMO).

J. Reiffers, P. Hervé, G. Socié, 1991, International journal of radiation oncology, biology, physics.

p62/SQSTM1 upregulation constitutes a survival mechanism that occurs during granulocytic differentiation of acute myeloid leukemia cells

M. Tschan, E. Ségal-Bendirdjian, J. Reiffers, 2014, Cell Death and Differentiation.

Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia.

M. Krajinovic, B. Turcq, J. Reiffers, 2008, Blood.

Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM)

A. Baruchel, H. Tilly, D. Blaise, 2000, Bone Marrow Transplantation.

D. Blaise, J. Reiffers, E. Archimbaud, 1992, Blood.

Modalities of synthesis of Ki67 antigen during the stimulation of lymphocytes.

F. Lacombe, J. Reiffers, F. Belloc, 1991, Cytometry.

Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia

F Lacombe, F. Durrieu, F. Lacombe, 1997, Leukemia.

A flow cytometric method using Hoechst 33342 and propidium iodide for simultaneous cell cycle analysis and apoptosis determination in unfixed cells.

F Lacombe, F. Lacombe, J. Reiffers, 1994, Cytometry.

Severe prolonged red blood cell aplasia and thrombocytopenia induced by parvovirus B19 infection in a patient with sarcoidosis.

J. Reiffers, J. Viallard, G. Marit, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Nitric oxide induces the apoptosis of human BCR-ABL-positive myeloid leukemia cells: evidence for the chelation of intracellular iron

J. Reiffers, G. Marit, M. Dupouy, 2002, Leukemia.

[Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].

F. Lacombe, J. Reiffers, J. Viallard, 2001, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models.

J. Melo, F. Moreau-Gaudry, J. Goldman, 2003, Blood.

Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance.

J. Melo, M. Deininger, J. Goldman, 2000, Blood.

Autologous blood stem cell transplantation followed by recombinant alpha interferon as treatment for patients with high-risk chronic myelogenous leukemia. A report of 32 cases.

P. Cony-Makhoul, J. Reiffers, G. Marit, 1993, Leukemia & lymphoma.

Study of apoptosis-related responses of leukemic blast cells to in vitro anthracycline treatment

F. Durrieu, F. Lacombe, J. Reiffers, 2000, Leukemia.

Synthesis of Bcl-2 in response to anthracycline treatment may contribute to an apoptosis-resistant phenotype in leukemic cell lines.

F. Durrieu, F. Lacombe, J. Reiffers, 1999, Cytometry.

Chronic myeloid leukemia and interferon-alpha: a study of complete cytogenetic responders.

M. Baccarani, H. Kluin-Nelemans, G. Rosti, 2001, Blood.

leukemia cell line models MDR1 gene overexpression confers resistance to imatinib mesylate in

J. Melo, F. Moreau-Gaudry, J. Goldman, 2013 .

Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia in first remission: a cooperative study of the Groupe d'Etude de la Greffe de Moelle Osseuse.

A. Fischer, J. Reiffers, E. Gluckman, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia.

Nicholas Moore, N. Moore, J. Reiffers, 2007, Blood.

Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial.

Philippe Rousselot, J. Reiffers, P. Rousselot, 2010, The Lancet. Oncology.

Multicenter independent assessment of outcomes in chronic myeloid leukemia patients treated with imatinib.

A. Nagler, M. Deininger, M. Valsecchi, 2011, Journal of the National Cancer Institute.

Discontinuation of Imatinib Therapy After Achieving a Molecular Response in Chronic Myeloid Leukemia Patients.

J. Reiffers, P. Rousselot, F. Mahon, 2009 .

Genomic acute myeloid leukemia-associated inv(16)(p13q22) breakpoints are tightly clustered

C. Wijmenga, A. Hagemeijer, J. Gabert, 1999, Oncogene.

Long‐acting β2‐adrenergic formoterol and salmeterol induce the apoptosis of B‐chronic lymphocytic Leukaemia cells

J. Reiffers, G. Marit, M. Mamani-Matsuda, 2004, British journal of haematology.

Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation. A follow-up report of the French protocol LALA 87.

C. Sebban, É. Lepage, J. Reiffers, 2000, Hematology/oncology clinics of North America.

myelogenous leukemia using flow cytometry Detection of cytarabine resistance in patients with acute

F. Lacombe, J. Reiffers, F. Belloc, 2011 .

Detection of cytarabine resistance in patients with acute myelogenous leukemia using flow cytometry.

F. Lacombe, J. Reiffers, F. Belloc, 1994, Blood.

Allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moelle.

G. Leverger, D. Blaise, J. Reiffers, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase 2 study of the oral farnesyltransferase inhibitor tipifarnib in patients with refractory or relapsed acute myeloid leukemia.

Pierre Fenaux, R. Stone, P. Fenaux, 2007, Blood.

Intensive chemotherapy versus bone marrow transplantation in pediatric acute myeloid leukemia : a matter of controversies

D. Blaise, J. Reiffers, N. Ifrah, 2001 .

Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome with rich marrow.

M. Labopin, J. Reiffers, O. Ringdén, 2003, Blood.

Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft

T. Barbui, M. Labopin, G. Meloni, 1999, Bone Marrow Transplantation.

Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years.

J. Cayuela, J. Reiffers, P. Rousselot, 2005, Blood.

European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching

M. Labopin, A. Nagler, J. Reiffers, 1997, Bone Marrow Transplantation.

A pilot study of autologous bone marrow transplantation followed by recombinant interleukin-2 in malignant lymphomas.

D. Blaise, J. Reiffers, P. Tiberghien, 1996, Leukemia & lymphoma.

The TAM regimen prior to allogeneic and autologous bone marrow transplantation for high-risk acute lymphoblastic leukemias: a cooperative study of 62 patients.

J. Bergerat, J. Reiffers, P. Colombat, 1991, Bone marrow transplantation.

Autologous peripheral-blood progenitor-cell support following high-dosechemotherapy or chemoradiotherapy in patients with high-risk multiple myeloma.

J. Bourhis, P. Cony-Makhoul, J. Reiffers, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation

J. Bourhis, D. Blaise, M. Mohty, 2003, Leukemia.

Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European survey.

M. Labopin, J. Reiffers, O. Ringdén, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia

D. Blaise, J. Reiffers, M. Tanguy, 2000, British journal of haematology.

Plasma cytokines in graft vs host disease and complications following bone marrow transplantation.

J. Reiffers, A. Cassaigne, A. Iron, 1997, Hematology and cell therapy.

Prospective randomized study of GVHD prevention using an anti IL2 receptor (CD25) MoAb after allogeneic bone marrow transplantation (BMT).

D. Olive, D. Blaise, J. Reiffers, 1991, Bone marrow transplantation.

Role of splenectomy in incidence and severity of acute graft-versus-host disease: a multicenter study of 157 patients.

J. Reiffers, C. Chabannon, J. Bosson, 1991, Bone marrow transplantation.

aplastic anemia antithymocyte globulin with prednisone for treatment of severe Multicenter randomized study comparing cyclosporine-A alone and

A. Baruchel, G. Leverger, J. Reiffers, 2013 .

Ex-Vivo Expanded Peripheral Blood Stem Cells (EVEC) Compared with Un Manipulated Peripheral Blood Stem Cells (PBSC) Autologous Transplantation for Multiple Myeloma: A Pair Match Analysis.

J. Reiffers, G. Marit, A. Schmitt, 2009 .

A clinical‐scale expansion of mobilized CD34+ hematopoietic stem and progenitor cells by use of a new serum‐free medium

I. Lamrissi‐Garcia, J. Reiffers, V. Praloran, 2006, Transfusion.

Large‐scale expansion and transplantation of CD34+ hematopoietic cells: in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long‐term engraftment capacity

J. Reiffers, G. Marit, F. Mazurier, 2006, Transfusion.

Ex vivo expansion of haematopoietic progenitors on an endothelialized hydroxyapatite matrix

L. Bordenave, F. Rouais, J. Reiffers, 1997, Journal of materials science. Materials in medicine.

Selective depletion of marrow-T cytotoxic lymphocytes (CD8) in the prevention of graft-versus-host disease after allogeneic bone-marrow transplantation

J. Reiffers, D. Maraninchi, J. Vernant, 1988 .

Radiobiological features of acute myeloblastic leukemia: comparison of self-renewal versus terminally differentiated populations.

D. Cowen, J. Reiffers, N. Gualde, 1994, International journal of radiation oncology, biology, physics.

AUTOLOGOUS BLOOD STEM CELL TRANSPLANTATION IN HIGH‐RISK MULTIPLE MYELOMA

J. Reiffers, G. Marit, J. Boiron, 1989, British journal of haematology.

Factors affecting both peripheral blood progenitor cell mobilization and hematopoietic recovery following autologous blood progenitor cell transplantation in multiple myeloma patients: a monocentric study

P. Cony-Makhoul, J. Reiffers, G. Marit, 1998, Leukemia.

Autologous blood stem cell transplantation (ABSCT) in high-risk myeloma (MM).

P. Cony-Makhoul, J. Reiffers, G. Marit, 1991, Bone marrow transplantation.

Autologous blood stem cell grafting in hematological malignancies. Present status and future directions.

P. Cony-Makhoul, J. Reiffers, G. Marit, 1992, Transfusion science.

European Cooperative Group for Bone Marrow Transplantation Bone marrow transplantation in multiple myeloma: report from the

G. Gahrton, A. Gratwohl, J. Reiffers, 2011 .

An update of prognostic factors for allogeneic bone marrow transplantation in multiple myeloma using matched sibling donors

G. Gahrton, A. Gratwohl, J. Reiffers, 1995, Stem cells.

Use of an anti-interleukin-2 receptor monoclonal antibody for GVHD prophylaxis in unrelated donor BMT.

J. Reiffers, X. Troussard, P. Hervé, 1993, Bone marrow transplantation.

Mobilized blood stem cells: immunophenotyping and functional characteristics.

J. Reiffers, A. Rice, 1992, Journal of hematotherapy.

High fluorescence reticulocytes are an indicator of bone marrow recovery after chemotherapy

F. Lacombe, J. Reiffers, G. Marit, 1995, European journal of haematology.

Allogeneic bone marrow transplantation in patients with multiple myeloma

M. Gore, G. Gahrton, A. Gratwohl, 1989, European journal of haematology. Supplementum.

Blood Stem Cell Transplantation in Acute Myeloid Leukemia

J. Reiffers, 1998 .

Reply to J. Richter et al.

J. Cayuela, P. Cony-Makhoul, M. Tulliez, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long Term Follow-Up After Imatinib Cessation For Patients Indeep Molecular Response: The Update Results Of The STIM1 Study

J. Reiffers, P. Rousselot, F. Guilhot, 2013 .

Loss Of Major Molecular Response As a Trigger For Restarting Tyrosine Kinase Inhibitor Therapy In CP-CML Patients Who Have Stopped Imatinib After Durable Undetectable Minimal Residual Disease

J. Cayuela, P. Cony-Makhoul, M. Tulliez, 2013 .

Allogeneic Transplantation for Patients with Advanced Acute Leukemia: a Single Center Retrospective Study of 92 Patients

P. Cony-Makhoul, J. Reiffers, G. Marit, 2001, Leukemia & lymphoma.

Donor bone marrow treatment with T101 Fab fragment-ricin A-chain immunotoxin prevents graft-versus-host disease.

J. Reiffers, G. Laurent, E. Gluckman, 1989, Bone marrow transplantation.

Total body irradiation–high‐dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA‐identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy: a Société Française de Greffe de Moelle study

G. Leverger, P. Rohrlich, J. Reiffers, 1998, British journal of haematology.

Bcr-abl translocation can occur during the induction of multidrug resistance and confers apoptosis resistance on myeloid leukemic cell lines

F. Durrieu, F. Lacombe, J. Reiffers, 1997, Cell Death and Differentiation.

A systematic collaborative overview of randomized trials comparing idarubicin with daunorubicin (or other anthracyclines) as induction therapy for acute myeloid leukaemia

R. Peto, F. Mandelli, R. Gray, 1998, British journal of haematology.

Correction of the enzyme deficit of bone marrow cells in congenital erythropoietic porphyria by retroviral gene transfer.

C. Ged, F. Moreau-Gaudry, J. Reiffers, 1996, Hematology and cell therapy.

Prospective Study Comparing Idarubicin and Daunorubicin in Elderly Patients with Acute Myeloid Leukemia

P. Cony-Makhoul, J. Reiffers, P. Hurteloup, 1992 .

Toxicity Profile of Idarubicin: Experiences with Oral and Intravenous Idarubicin in the Treatment of Leukemia

J. Reiffers, J. Harousseau, F. Rigal‐Huguet, 1992 .

Differential effect of interferon α on chronic myelogenous leukaemia and normal haematopoietic progenitors in a stromal cell co‐culture context: role of the flt3 ligand

J. Reiffers, G. Marit, J. Ripoche, 2000, British journal of haematology.

Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML): a survey of 110 cases from the French AML Intergroup.

H. Dombret, G. Leverger, D. Blaise, 2003, Blood.

P. Cony-Makhoul, D. Cowen, J. Reiffers, 1992, Bone marrow transplantation.

Reassessing autotransplantation for acute myeloid leukaemia in first remission – a matched pair analysis of autologous marrow vs peripheral blood stem cells

S. Singhal, J. Mehta, M. Labopin, 2004, Bone Marrow Transplantation.

Flow cytometric estimation of poly(A)+ RNA by fluorescent in situ hybridization.

F. Lacombe, J. Reiffers, F. Belloc, 1993, Cytometry.

Fractionated or single-dose total body irradiation in 171 acute myeloblastic leukemias in first complete remission: is there a best choice? SFGM. Société Française de Greffe de Moelle.

D. Blaise, D. Cowen, J. Reiffers, 1995, International journal of radiation oncology, biology, physics.

Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia.

C. Sebban, É. Lepage, J. Reiffers, 1994, Journal of Clinical Oncology.

Prior treatment with alpha interferon does not adversely  affect the outcome of allogeneic transplantation  for chronic myeloid leukaemia

J. Reiffers, O. Reman, N. Ifrah, 2002, British journal of haematology.

Short communication Derivative (7)t(7;8)(q34;q21): a new additional cytogenetic abnormality in acute promyelocytic leukemia

J. Vial, F. Lacombe, J. Reiffers, 2003 .

Derivative (7)t(7;8)(q34;q21). a new additional cytogenetic abnormality in acute promyelocytic leukemia.

J. Vial, F. Lacombe, J. Reiffers, 2003, Cancer genetics and cytogenetics.

5-Fluorouracil-resistant CD34+ cell population from peripheral blood of CML patients contains BCR-ABL-negative progenitor cells.

J. Reiffers, A. Pigneux, F. Mahon, 1995, Experimental hematology.

Interferon gamma is effective for BM purging in a patient with CML.

J. Reiffers, M. Becker, V. Barbu, 1993, Bone marrow transplantation.

The use of a sequential high dose recombinant interleukin 2 regimen after autologous bone marrow transplantation does not improve the disease free survival of patients with acute leukemia transplanted in first complete remission.

D. Olive, D. Blaise, J. Reiffers, 1997, Leukemia & lymphoma.

IL2 in Acute Leukemia

R. Bouabdallah, D. Blaise, J. Reiffers, 1996 .

Autologous blood stem-cell transplantation and recombinant interferon alfa in chronic myeloid leukemia.

J. Reiffers, X. Troussard, V. Leblond, 1993, Seminars in hematology.

Blood Stem Cell Transplantation

J. Armitage, J. Goldman, J. Reiffers, 1998 .

Busulphan and melphalan prior to autologous transplantation for myeloid malignancies.

P. Cony-Makhoul, J. Reiffers, G. Marit, 1995, Bone marrow transplantation.

A phase II study of interleukin-2 in 49 patients with relapsed or refractory acute leukemia.

R. Bouabdallah, D. Olive, D. Blaise, 1998, Leukemia & lymphoma.

Risk assessment in adult acute lymphoblastic leukaemia before early haemopoietic stem cell transplantation with a geno-identical donor: an easy clinical prognostic score to identify patients who benefit most from allogeneic haemopoietic stem cell transplantation

M. Labopin, D. Blaise, J. Reiffers, 2003, Leukemia.

A comparison of toxicity following two different doses of cyclophosphamide for mobilization of peripheral blood progenitor cells in 116 multiple myeloma patients

P. Cony-Makhoul, J. Reiffers, G. Marit, 2001, Bone Marrow Transplantation.

The dismal outcome in patients with acute leukaemia who relapse after an autograft is improved if a second autograft or a matched allograft is performed

M. Labopin, D. Blaise, G. Meloni, 2000, Bone Marrow Transplantation.

BMT IN MULTIPLE MYELOMA — PROGNOSTIC FACTORS

A. Hagenbeek, A. Gratwohl, J. Reiffers, 2017 .

Stable mixed chimerism without relapse after related allogeneic umbilical cord blood transplantation in a child with severe aplastic anemia

P. Cony-Makhoul, J. Reiffers, F. Belloc, 1998, Bone Marrow Transplantation.

Fluorescent in situ hybridization on flow‐sorted cells as a tool for evaluating minimal residual disease or chimerism after allogeneic bone marrow transplantation

F. Lacombe, J. Reiffers, C. Boyer, 1998 .

Treatment of relapsed acute myeloid leukemia using GM-CSF before intensive chemotherapy.

P. Cony-Makhoul, F. Lacombe, J. Reiffers, 1993, Leukemia & lymphoma.

Role of blast cell immunophenotyping for the diagnosis and prognosis of acute myeloid leukemia

F. Lacombe, J. Reiffers, G. Marit, 1992, Hematological oncology.

FLOW CYTOMETRY AND DETECTION OF ARA‐C RESISTANT LEUKEMIC CELLS

F. Lacombe, J. Reiffers, F. Belloc, 1991 .

Influence of rhGM-CSF on Ara-C sensitivity of patients with acute myeloid leukemia in relapse: a flow cytometry study.

P. Cony-Makhoul, F. Lacombe, J. Reiffers, 1996, Leukemia research.

A white blood cell index as the main prognostic factor in t ( 8 ; 21 ) acute myeloid leukemia ( AML ) : a survey of 161 cases from the French AML Intergroup

H. Dombret, G. Leverger, D. Blaise, 2002 .

Adding lomustine to idarubicin and cytarabine for induction chemotherapy in older patients with acute myeloid leukemia: the BGMT 95 trial results

J. Reiffers, N. Ifrah, N. Vey, 2007, Haematologica.

Addition of lomustine to idarubicin and cytarabine improves the outcome of elderly patients with de novo acute myeloid leukemia: a report from the GOELAMS.

M. Béné, J. Reiffers, C. Récher, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Collection of peripheral blood stem cells in multiple myeloma following single high-dose cyclophosphamide with and without recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF).

P. Cony-Makhoul, J. Reiffers, G. Marit, 1993, Bone marrow transplantation.

AUTOGRAFTING FOR CHRONIC GRANULOCYTIC LEUKAEMIA IN ACCELERATED PHASE

J. Reiffers, P. Hervé, D. Maraninchi, 1985, British journal of haematology.

BURKITT‐TYPE ACUTE LYMPHOBLASTIC LEUKEMIA IN DONOR CELLS AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION FOR ACUTE NONLYMPHOBLASTIC LEUKEMIA

P. Cony-Makhoul, J. Reiffers, G. Marit, 1993, Transplantation.

Allogeneic bone marrow transplantation for acute leukemia in patients over the age of 40 years. Acute Leukemia Working Party of the European Group for Bone Marrow Transplantation (EBMT).

M. Labopin, A. Gratwohl, J. Reiffers, 1997, Leukemia.

Allogeneic bone marrow transplantation for acute leukemia in patients over the age of 40 years

M. Labopin, R. Willemze, A. Gratwohl, 1997, Leukemia.

Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Société Française de Greffe de Moelle.

C. Chastang, J. Reiffers, X. Troussard, 1996, Blood.

analysis of the European Bone Marrow Transplant Group retrospective myeloblastic leukemia in patients older than 50 years: a Autologous bone marrow transplantation for first remission acute

F. Mandelli, M. Labopin, A. Gratwohl, 2011 .

Randomized study of recombinant interleukin-2 after autologous bone marrow transplantation for acute leukemia in first complete remission.

J. Rossi, R. Bouabdallah, D. Blaise, 2000, European cytokine network.

Treatment of Relapsed Acute Myeloid Leukemia with Granulocyte-Macrophage Colony-Stimulating Factor and Intensive Chemotherapy

P. Cony-Makhoul, F. Lacombe, J. Reiffers, 1992 .

Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

T. Barbui, M. Labopin, G. Meloni, 1999, Bone marrow transplantation.

Allogeneic and Autologous Bone Marrow Transplantation and Chemotherapy in First Remission of Adult Acute Lymphoblastic Leukemia: Results of the LALA 87 Trial of the French Group

É. Lepage, J. Reiffers, J. Vernant, 1997 .

Autologous stem cell transplantation for chronic myeloid leukemia.

P. Cony-Makhoul, J. Reiffers, G. Marit, 1998, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Noninvasive continuous positive airway pressure in neutropenic patients with acute respiratory failure requiring intensive care unit admission

J. Reiffers, D. Gruson, G. Chêne, 2000, Critical Care Medicine.

The Use of Long-Term Culture Techniques to Study Peripheral Blood Stem Cells Before and After Autologous Transplantation

P. Cony-Makhoul, F. Lacombe, J. Reiffers, 1993 .

Possible Effect of Autologous Blood Stem Cell Transplantation on Outcome of Acute Myeloid Leukemia in First Relapse

P. Cony-Makhoul, J. Reiffers, G. Marit, 1992 .

Treatment of acute myeloid leukemia in elderly patients: the influence of maintenance therapy (BGM 84 protocol).

J. Reiffers, G. Marit, D. Maraninchi, 1990, Nouvelle revue francaise d'hematologie.

PERIPHERAL BLOOD STEM-CELL TRANSPLANTATION IN INTENSIVE TREATMENT OF MULTIPLE MYELOMA

J. Reiffers, G. Marit, J. Boiron, 1989, The Lancet.

Is there a place for blood stem-cell transplantation for the younger adult patient with acute myelogenous leukemia? BGMT Group.

J. Reiffers, M. Attal, A. Stoppa, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chronic myeloid leukemia in first chronic phase not responding to alpha-interferon: outcome and prognostic factors after autologous transplantation. EBMT Working Party on Chronic Leukemias.

G. Meloni, J. Reiffers, C. Carlo-Stella, 1999, Bone marrow transplantation.

High response rate using recombinant interferon-alpha in patients with newly diagnosed chronic myeloid leukemia.

P. Cony-Makhoul, J. Reiffers, G. Marit, 1996, Bone marrow transplantation.

Autologous transplantation in chronic myelogenous leukemia: European results: Chronic Leukemia Working Party of the EBMT.

G. Meloni, J. Reiffers, J. Apperley, 1994, Bone marrow transplantation.

(EBMT) study of the European Group for Blood and Marrow Transplantation Hematopoietic stem cell transplantation for de novo erythroleukemia: a

M. Labopin, R. Willemze, G. Meloni, 2013 .

Hematopoietic stem cell transplantation for de novo erythroleukemia: a study of the European Group for Blood and Marrow Transplantation (EBMT).

M. Labopin, R. Willemze, G. Meloni, 2002, Blood.

Incidence of relapse following blood stem cell transplantation for acute myeloid leukemia in first remission.

J. Reiffers, 1996, Bone marrow transplantation.

Expansion of blood CD34+ cells: committed precursor expansion does not affect immature hematopoietic progenitors.

J. Reiffers, A. Rice, I. Vianes, 1997, Journal of hematotherapy.

Autologous blood progenitor cell transplantation in high‐risk multiple myeloma

P. Cony-Makhoul, J. Reiffers, M. Bonnefoy, 1995, Stem cells.

Autologous stem cell transplantation in chronic myeloid leukemia: a single center experience

P. Cony-Makhoul, J. Reiffers, G. Marit, 1999, Bone Marrow Transplantation.

Fluorescent in situ hybridization on flow-sorted cells as a tool for evaluating minimal residual disease or chimerism after allogenic bone marrow transplantation.

F. Lacombe, J. Reiffers, C. Boyer, 1998, Cytometry.

Effect of Antisense Oligonucleotides on CD34+ Cells from Chronic Myeloid Leukemia

J. Reiffers, A. Pigneux, E. Mahon, 2000, Leukemia & lymphoma.

The In Vitro Effect of Interferon-γ on Chronic Myeloid Leukemia Cells

J. Reiffers, G. Marit, M. Becker, 1992 .

Leukaemia inhibitory factor expression is inhibited by glucocorticoids through post-transcriptional mechanisms.

J. Reiffers, J. Ripoche, J. Taupin, 1999, Cytokine.

[Chronic myeloid leukemia. Diagnosis, course, prognosis].

J. Reiffers, F. Mahon, 1996, La Revue du praticien.

Predicting complete cytogenetic response in chronic myelogenous leukemia patients treated with recombinant interferon alpha.

J. Reiffers, F. Mahon, F. Mahon, 1994, Blood.

Is It Possible to Stop Imatinib in Patients with Chronic Myeloid Leukemia? An Update from a French Pilot Study and First Results from the Multicentre « Stop Imatinib » (STIM) Study

J. Reiffers, P. Rousselot, F. Mahon, 2008 .

Enestnd 4-Year (y) Update: Continued Superiority of Nilotinib Vs Imatinib in Patients (pts) with Newly Diagnosed Philadelphia Chromosome–Positive (Ph+) Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

R. Larson, R. Clark, H. Kantarjian, 2012 .

Flt3‐ligand induces adhesion of haematopoietic progenitor cells via a very late antigen (VLA)‐4‐ and VLA‐5‐dependent mechanism

J. Reiffers, Patrick Legembre, J. Viallard, 2003, British journal of haematology.

responders : a study of complete cytogenetic α Chronic myeloid leukemia and interferon-

J. Hasford, M. Baccarani, G. Rosti, 2013 .

Discontinuation of Imatinib in Patients with Chronic Myeloid Leukemia Who Have Maintained Complete Molecular Response: Update Results of the STIM Study

J. Reiffers, P. Rousselot, F. Mahon, 2011 .

Use of recombinant IL-2 (RU49637) after autologous bone marrow transplantation (BMT) in patients with hematological neoplasias: a phase 1 study.

D. Olive, D. Blaise, J. Reiffers, 1991, Bone marrow transplantation.

Mutation in the ATP‐binding site of BCR‐ABL in a patient with chronic myeloid leukaemia with increasing resistance to STI571

C. Barthe, P. Cony-Makhoul, J. Melo, 2002, British journal of haematology.

Achieving a Complete Molecular Remission Under Imatinib Therapy Is Associated with a Better Outcome in Chronic Phase Chronic Myeloid Leukaemia Patients On Imatinib Frontline Therapy

J. Reiffers, E. Lippert, S. Hayette, 2012 .

Simple method for detection of MYH11 DNA rearrangements in patients with inv(16)(p13q22) and acute myeloid leukemia.

A. Hagemeijer, J. Reiffers, M. Breuning, 1996, Leukemia.

Role of iron in tumor cell protection from the pro-apoptotic effect of nitric oxide.

A. Nussler, J. Reiffers, M. Dupouy, 2001, Cancer research.

[Treatment of acute myeloid leukemia in adults].

F. Lacombe, J. Reiffers, M. Puntous, 1996, La Revue du praticien.

European results of unrelated cord blood transplants

F. Locatelli, A. Nagler, P. Veys, 1998 .

Interferon Alpha Alone Is Able to Cure Chronic Myeloid Leukemia In a Small Subset of Patients Despite the Persistence of Leukemic Cells: Experience of Long Follow up After Treatment Discontinuation

P. Cony-Makhoul, J. Reiffers, G. Marit, 2010 .

Role of blast cell immunophenotyping for the diagnosis and prognosis of acute myeloid leukemia

F. Lacombe, J. Reiffers, F. Belloc, 1992 .

Peripheral blood progenitor cell transplantation in France.

J. Reiffers, M. Tanguy, C. Faberes, 1995, Nouvelle revue francaise d'hematologie.

Clinical original contributionFractionated or single-dose total body irradiation in 171 acute myeloblastic leukemias in first complete remission: Is there a best choice?☆

D. Blaise, D. Cowen, J. Reiffers, 1995 .

Long-term culture of peripheral blood stem cells: the effect of the addition of an irradiated stromal layer.

F. Lacombe, J. Reiffers, G. Marit, 1989, Experimental Hematology.

Very early allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission A report from the Societe Francaise de Greffe de Moelle

D. Blaise, J. Reiffers, E. Archimbaud, 1994 .

A multicenter randomized study comparing cyclosporin-A alone and antithymocyte globulin with prednisone for treatment of severe aplastic anemia. The cooperative group on the treatment of aplastic anemia.

A. Baruchel, G. Leverger, J. Reiffers, 1992, Journal of Autoimmunity.

Chronic myelocytic leukemia patients achieving complete cytogenetic conversion under interferon alpha therapy: minimal residual disease follow-up.

J. Reiffers, G. Marit, F. Mahon, 1995, Leukemia.

Anti LFA1 monoclonal antibody for the prevention of graft rejection after T cell-depleted HLA-matched bone marrow transplantation for leukemia in adults.

D. Olive, J. Reiffers, G. Marit, 1989, Bone marrow transplantation.

Persistence of complete molecular remission in chronic myeloid leukemia after imatinib discontinuation: Interim analysis of the STIM trial.

J. Reiffers, P. Rousselot, F. Guilhot, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Development of an efficient serum-free semisolid culture system for the evaluation of hematopoietic progenitors.

J. Reiffers, C. Barbot, A. Rice, 1995, Journal of hematotherapy.

Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years.

J. Cayuela, J. Reiffers, P. Rousselot, 2007, Blood.

Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial

J. Reiffers, P. Rousselot, F. Mahon, 2010 .

A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML): a survey of 161 cases from the French AML Intergroup.

H. Dombret, G. Leverger, D. Blaise, 2002, Blood.

110 cases from the French AML Intergroup Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML): a survey of

G. Leverger, D. Blaise, J. Reiffers, 2013 .

Long-term Follow-up of a Randomized Trial Comparing the Combination of Cyclophosphamide with Total Body Irradiation or Busulfan as Conditioning Regimen for Patients Receiving Hla- Identical Marrow Grafts for Acute Myeloblastic Leukemia in First Complete Remission

D. Blaise, J. Reiffers, N. Ifrah, 2022 .

Proteasome inhibitIon specifically sensitizes leukemic cells to anthracyclin-induced apoptosis through the accumulation of Bim and Bax pro-apoptotic proteins

F. Lacombe, F. Moreau-Gaudry, J. Reiffers, 2007, Cancer biology & therapy.

Imatinib Mesylate Discontinuation in Patients with Chronic Myelogenous Leukemia in Complete Molecular Remission: An Update Follow Up.

J. Cayuela, J. Reiffers, G. Marit, 2006 .

Expression of neurotrophins and their receptors in human bone marrow.

P Dubus, F X Mahon, P. Dubus, 1999, The American journal of pathology.

A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group.

R. Bouabdallah, H. Dombret, F. Mandelli, 1995, The New England journal of medicine.

Oral idarubicin and low dose cytarabine as the initial treatment of acute myeloid leukemia in elderly patients.

J. Reiffers, P. Hurteloup, P. Collombat, 1991, Leukemia & lymphoma.

Chemotherapy versus transplants for acute myelogenous leukemia in second remission.

J. Klein, M. Oken, R. Gray, 1996, Leukemia.

The long term outcome of the patients with chronic myeloid leukemia (CML) who have achieved complete cytogenetic response (CCgR) to interferon-alpha (IFN alpha). A collaborative European study of 317 cases.

M. Baccarani, G. Martinelli, S. Richards, 2001 .

Detection of resistance to STI571 in patients with BCR-ABL positive acute leukemia and chronic myeloid leukemia blast crisis

J. Melo, J. Reiffers, P. Berthaud, 2000 .

Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups

A. Deisseroth, J. Goldman, J. Reiffers, 1994, The Lancet.

Impact of colony-stimulating factor therapy on clinical outcome and frequency rate of nosocomial infections in intensive care unit neutropenic patients

J. Reiffers, D. Gruson, G. Chêne, 2000, Critical care medicine.

A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML): a survey of 161 cases from the French AML Intergroup.

H. Dombret, G. Leverger, D. Blaise, 2002, Blood.

Achieving deeper molecular response is associated with a better clinical outcome in chronic myeloid leukemia patients on imatinib front-line therapy

J. Reiffers, E. Lippert, S. Hayette, 2014, Haematologica.

Blood cell transplantation: past, present and future.

J. Reiffers, J. Boiron, Ray M. Lowenthal, 1996, Hematology and cell therapy.

INTENSIVE INDUCTION CHEMOTHERAPY IN ELDERLY PATIENTS

J. Reiffers, P. Hurteloup, A. Stoppa, 1992 .

A. Grañena, G. Gahrton, M. Labopin, 1996, Bone marrow transplantation.

Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remission.

M. Labopin, D. Blaise, G. Meloni, 2010, Blood.

Triptolide cooperates with chemotherapy to induce apoptosis in acute myeloid leukemia cells.

F. Lacombe, J. Reiffers, F. Mahon, 2008, Experimental hematology.

[Allogeneic bone marrow transplantation in multiple myeloma].

M. Gobbi, J. Reiffers, P. Tazzari, 1991, Haematologica.